[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Global Biopharmaceutical Logistic Market Analysis and Forecast 2024-2030

April 2024 | 205 pages | ID: G1947CC66A17EN
APO Research

US$ 4,950.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
Summary

Biopharmaceutical Logistics is the logistics of Biopharmaceutical, medical and surgical supplies, and other products needed to support doctors, nurses, and other health and dental care providers. Because it’s final customers are responsible for the lives and health of their patients, medical logistics is unique in that it seeks to optimize effectiveness rather than efficiency. Medical logistics functions comprise an important part of the health care system: after staff costs, medical supplies are the single most expensive component of health care. To drive costs out of the health-care sector, medical logistics providers are adopting supply chain management theories.

According to APO Research, The global Biopharmaceutical Logistic market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Biopharmaceutical Logistic is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

Asia-Pacific market for Biopharmaceutical Logistic is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

The China market for Biopharmaceutical Logistic is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

Europe market for Biopharmaceutical Logistic is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

The major global companies of Biopharmaceutical Logistic include Deutsche Post DHL, Kuehne + Nagel, FedEx, AmerisourceBergen, UPS (Marken), DB Schenker, XPO Logistics, Panalpina and Nippon Express, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.

Report Includes

This report presents an overview of global market for Biopharmaceutical Logistic, market size. Analyses of the global market trends, with historic market revenue data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.

This report researches the key producers of Biopharmaceutical Logistic, also provides the revenue of main regions and countries. Of the upcoming market potential for Biopharmaceutical Logistic, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Biopharmaceutical Logistic revenue, market share and industry ranking of main manufacturers, data from 2019 to 2024. Identification of the major stakeholders in the global Biopharmaceutical Logistic market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2019 to 2030. Evaluation and forecast the market size for Biopharmaceutical Logistic revenue, projected growth trends, production technology, application and end-user industry.

Biopharmaceutical Logistic segment by Company
  • Deutsche Post DHL
  • Kuehne + Nagel
  • FedEx
  • AmerisourceBergen
  • UPS (Marken)
  • DB Schenker
  • XPO Logistics
  • Panalpina
  • Nippon Express
  • GEODIS
  • VersaCold
  • Agility
  • DSV
  • Sinotrans
  • Kerry Logistics
  • SF Express
  • CEVA
  • CH Robinson
  • Air Canada Cargo
Biopharmaceutical Logistic segment by Type
  • Cold Chain Logistics
  • Non-cold Chain Logistics
Biopharmaceutical Logistic segment by Application
  • Ground Shipping
  • Sea Shipping
  • Air Shipping
Biopharmaceutical Logistic segment by Region
  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • France
    • U.K.
    • Italy
    • Russia
  • Asia-Pacific
    • China
    • Japan
    • South Korea
    • India
    • Australia
    • China Taiwan
    • Indonesia
    • Thailand
    • Malaysia
  • Latin America
    • Mexico
    • Brazil
    • Argentina
  • Middle East & Africa
    • Turkey
    • Saudi Arabia
    • UAE
Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key players, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Biopharmaceutical Logistic market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Biopharmaceutical Logistic and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Biopharmaceutical Logistic.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Revenue of Biopharmaceutical Logistic in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 4: Detailed analysis of Biopharmaceutical Logistic company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Biopharmaceutical Logistic revenue, gross margin, and recent development, etc.

Chapter 8: North America (US & Canada) by type, by application and by country, revenue for each segment.

Chapter 9: Europe by type, by application and by country, revenue for each segment.

Chapter 10: China type, by application, revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.

Chapter 12: Middle East, Africa, and Latin America type, by application and by country, revenue for each segment.

Chapter 13: The main concluding insights of the report.
1 MARKET OVERVIEW

1.1 Product Definition
1.2 Biopharmaceutical Logistic Market by Type
  1.2.1 Global Biopharmaceutical Logistic Market Size by Type, 2019 VS 2023 VS 2030
  1.2.2 Cold Chain Logistics
  1.2.3 Non-cold Chain Logistics
1.3 Biopharmaceutical Logistic Market by Application
  1.3.1 Global Biopharmaceutical Logistic Market Size by Application, 2019 VS 2023 VS 2030
  1.3.2 Ground Shipping
  1.3.3 Sea Shipping
  1.3.4 Air Shipping
1.4 Assumptions and Limitations
1.5 Study Goals and Objectives

2 BIOPHARMACEUTICAL LOGISTIC MARKET DYNAMICS

2.1 Biopharmaceutical Logistic Industry Trends
2.2 Biopharmaceutical Logistic Industry Drivers
2.3 Biopharmaceutical Logistic Industry Opportunities and Challenges
2.4 Biopharmaceutical Logistic Industry Restraints

3 GLOBAL GROWTH PERSPECTIVE

3.1 Global Biopharmaceutical Logistic Market Perspective (2019-2030)
3.2 Global Biopharmaceutical Logistic Growth Trends by Region
  3.2.1 Global Biopharmaceutical Logistic Market Size by Region: 2019 VS 2023 VS 2030
  3.2.2 Global Biopharmaceutical Logistic Market Size by Region (2019-2024)
  3.2.3 Global Biopharmaceutical Logistic Market Size by Region (2025-2030)

4 COMPETITIVE LANDSCAPE BY PLAYERS

4.1 Global Biopharmaceutical Logistic Revenue by Players
  4.1.1 Global Biopharmaceutical Logistic Revenue by Players (2019-2024)
  4.1.2 Global Biopharmaceutical Logistic Revenue Market Share by Players (2019-2024)
  4.1.3 Global Biopharmaceutical Logistic Players Revenue Share Top 10 and Top 5 in 2023
4.2 Global Biopharmaceutical Logistic Key Players Ranking, 2022 VS 2023 VS 2024
4.3 Global Biopharmaceutical Logistic Key Players Headquarters & Area Served
4.4 Global Biopharmaceutical Logistic Players, Product Type & Application
4.5 Global Biopharmaceutical Logistic Players Commercialization Time
4.6 Market Competitive Analysis
  4.6.1 Global Biopharmaceutical Logistic Market CR5 and HHI
  4.6.2 Global Top 5 and 10 Biopharmaceutical Logistic Players Market Share by Revenue in 2023
  4.6.3 2023 Biopharmaceutical Logistic Tier 1, Tier 2, and Tier

5 BIOPHARMACEUTICAL LOGISTIC MARKET SIZE BY TYPE

5.1 Global Biopharmaceutical Logistic Revenue by Type (2019 VS 2023 VS 2030)
5.2 Global Biopharmaceutical Logistic Revenue by Type (2019-2030)
5.3 Global Biopharmaceutical Logistic Revenue Market Share by Type (2019-2030)

6 BIOPHARMACEUTICAL LOGISTIC MARKET SIZE BY APPLICATION

6.1 Global Biopharmaceutical Logistic Revenue by Application (2019 VS 2023 VS 2030)
6.2 Global Biopharmaceutical Logistic Revenue by Application (2019-2030)
6.3 Global Biopharmaceutical Logistic Revenue Market Share by Application (2019-2030)

7 COMPANY PROFILES

7.1 Deutsche Post DHL
  7.1.1 Deutsche Post DHL Comapny Information
  7.1.2 Deutsche Post DHL Business Overview
  7.1.3 Deutsche Post DHL Biopharmaceutical Logistic Revenue and Gross Margin (2019-2024)
  7.1.4 Deutsche Post DHL Biopharmaceutical Logistic Product Portfolio
  7.1.5 Deutsche Post DHL Recent Developments
7.2 Kuehne + Nagel
  7.2.1 Kuehne + Nagel Comapny Information
  7.2.2 Kuehne + Nagel Business Overview
  7.2.3 Kuehne + Nagel Biopharmaceutical Logistic Revenue and Gross Margin (2019-2024)
  7.2.4 Kuehne + Nagel Biopharmaceutical Logistic Product Portfolio
  7.2.5 Kuehne + Nagel Recent Developments
7.3 FedEx
  7.3.1 FedEx Comapny Information
  7.3.2 FedEx Business Overview
  7.3.3 FedEx Biopharmaceutical Logistic Revenue and Gross Margin (2019-2024)
  7.3.4 FedEx Biopharmaceutical Logistic Product Portfolio
  7.3.5 FedEx Recent Developments
7.4 AmerisourceBergen
  7.4.1 AmerisourceBergen Comapny Information
  7.4.2 AmerisourceBergen Business Overview
  7.4.3 AmerisourceBergen Biopharmaceutical Logistic Revenue and Gross Margin (2019-2024)
  7.4.4 AmerisourceBergen Biopharmaceutical Logistic Product Portfolio
  7.4.5 AmerisourceBergen Recent Developments
7.5 UPS (Marken)
  7.5.1 UPS (Marken) Comapny Information
  7.5.2 UPS (Marken) Business Overview
  7.5.3 UPS (Marken) Biopharmaceutical Logistic Revenue and Gross Margin (2019-2024)
  7.5.4 UPS (Marken) Biopharmaceutical Logistic Product Portfolio
  7.5.5 UPS (Marken) Recent Developments
7.6 DB Schenker
  7.6.1 DB Schenker Comapny Information
  7.6.2 DB Schenker Business Overview
  7.6.3 DB Schenker Biopharmaceutical Logistic Revenue and Gross Margin (2019-2024)
  7.6.4 DB Schenker Biopharmaceutical Logistic Product Portfolio
  7.6.5 DB Schenker Recent Developments
7.7 XPO Logistics
  7.7.1 XPO Logistics Comapny Information
  7.7.2 XPO Logistics Business Overview
  7.7.3 XPO Logistics Biopharmaceutical Logistic Revenue and Gross Margin (2019-2024)
  7.7.4 XPO Logistics Biopharmaceutical Logistic Product Portfolio
  7.7.5 XPO Logistics Recent Developments
7.8 Panalpina
  7.8.1 Panalpina Comapny Information
  7.8.2 Panalpina Business Overview
  7.8.3 Panalpina Biopharmaceutical Logistic Revenue and Gross Margin (2019-2024)
  7.8.4 Panalpina Biopharmaceutical Logistic Product Portfolio
  7.8.5 Panalpina Recent Developments
7.9 Nippon Express
  7.9.1 Nippon Express Comapny Information
  7.9.2 Nippon Express Business Overview
  7.9.3 Nippon Express Biopharmaceutical Logistic Revenue and Gross Margin (2019-2024)
  7.9.4 Nippon Express Biopharmaceutical Logistic Product Portfolio
  7.9.5 Nippon Express Recent Developments
7.10 GEODIS
  7.10.1 GEODIS Comapny Information
  7.10.2 GEODIS Business Overview
  7.10.3 GEODIS Biopharmaceutical Logistic Revenue and Gross Margin (2019-2024)
  7.10.4 GEODIS Biopharmaceutical Logistic Product Portfolio
  7.10.5 GEODIS Recent Developments
7.11 VersaCold
  7.11.1 VersaCold Comapny Information
  7.11.2 VersaCold Business Overview
  7.11.3 VersaCold Biopharmaceutical Logistic Revenue and Gross Margin (2019-2024)
  7.11.4 VersaCold Biopharmaceutical Logistic Product Portfolio
  7.11.5 VersaCold Recent Developments
7.12 Agility
  7.12.1 Agility Comapny Information
  7.12.2 Agility Business Overview
  7.12.3 Agility Biopharmaceutical Logistic Revenue and Gross Margin (2019-2024)
  7.12.4 Agility Biopharmaceutical Logistic Product Portfolio
  7.12.5 Agility Recent Developments
7.13 DSV
  7.13.1 DSV Comapny Information
  7.13.2 DSV Business Overview
  7.13.3 DSV Biopharmaceutical Logistic Revenue and Gross Margin (2019-2024)
  7.13.4 DSV Biopharmaceutical Logistic Product Portfolio
  7.13.5 DSV Recent Developments
7.14 Sinotrans
  7.14.1 Sinotrans Comapny Information
  7.14.2 Sinotrans Business Overview
  7.14.3 Sinotrans Biopharmaceutical Logistic Revenue and Gross Margin (2019-2024)
  7.14.4 Sinotrans Biopharmaceutical Logistic Product Portfolio
  7.14.5 Sinotrans Recent Developments
7.15 Kerry Logistics
  7.15.1 Kerry Logistics Comapny Information
  7.15.2 Kerry Logistics Business Overview
  7.15.3 Kerry Logistics Biopharmaceutical Logistic Revenue and Gross Margin (2019-2024)
  7.15.4 Kerry Logistics Biopharmaceutical Logistic Product Portfolio
  7.15.5 Kerry Logistics Recent Developments
7.16 SF Express
  7.16.1 SF Express Comapny Information
  7.16.2 SF Express Business Overview
  7.16.3 SF Express Biopharmaceutical Logistic Revenue and Gross Margin (2019-2024)
  7.16.4 SF Express Biopharmaceutical Logistic Product Portfolio
  7.16.5 SF Express Recent Developments
7.17 CEVA
  7.17.1 CEVA Comapny Information
  7.17.2 CEVA Business Overview
  7.17.3 CEVA Biopharmaceutical Logistic Revenue and Gross Margin (2019-2024)
  7.17.4 CEVA Biopharmaceutical Logistic Product Portfolio
  7.17.5 CEVA Recent Developments
7.18 CH Robinson
  7.18.1 CH Robinson Comapny Information
  7.18.2 CH Robinson Business Overview
  7.18.3 CH Robinson Biopharmaceutical Logistic Revenue and Gross Margin (2019-2024)
  7.18.4 CH Robinson Biopharmaceutical Logistic Product Portfolio
  7.18.5 CH Robinson Recent Developments
7.19 Air Canada Cargo
  7.19.1 Air Canada Cargo Comapny Information
  7.19.2 Air Canada Cargo Business Overview
  7.19.3 Air Canada Cargo Biopharmaceutical Logistic Revenue and Gross Margin (2019-2024)
  7.19.4 Air Canada Cargo Biopharmaceutical Logistic Product Portfolio
  7.19.5 Air Canada Cargo Recent Developments

8 NORTH AMERICA

8.1 North America Biopharmaceutical Logistic Revenue (2019-2030)
8.2 North America Biopharmaceutical Logistic Revenue by Type (2019-2030)
  8.2.1 North America Biopharmaceutical Logistic Revenue by Type (2019-2024)
  8.2.2 North America Biopharmaceutical Logistic Revenue by Type (2025-2030)
8.3 North America Biopharmaceutical Logistic Revenue Share by Type (2019-2030)
8.4 North America Biopharmaceutical Logistic Revenue by Application (2019-2030)
  8.4.1 North America Biopharmaceutical Logistic Revenue by Application (2019-2024)
  8.4.2 North America Biopharmaceutical Logistic Revenue by Application (2025-2030)
8.5 North America Biopharmaceutical Logistic Revenue Share by Application (2019-2030)
8.6 North America Biopharmaceutical Logistic Revenue by Country
  8.6.1 North America Biopharmaceutical Logistic Revenue by Country (2019 VS 2023 VS 2030)
  8.6.2 North America Biopharmaceutical Logistic Revenue by Country (2019-2024)
  8.6.3 North America Biopharmaceutical Logistic Revenue by Country (2025-2030)
  8.6.4 U.S.
  8.6.5 Canada

9 EUROPE

9.1 Europe Biopharmaceutical Logistic Revenue (2019-2030)
9.2 Europe Biopharmaceutical Logistic Revenue by Type (2019-2030)
  9.2.1 Europe Biopharmaceutical Logistic Revenue by Type (2019-2024)
  9.2.2 Europe Biopharmaceutical Logistic Revenue by Type (2025-2030)
9.3 Europe Biopharmaceutical Logistic Revenue Share by Type (2019-2030)
9.4 Europe Biopharmaceutical Logistic Revenue by Application (2019-2030)
  9.4.1 Europe Biopharmaceutical Logistic Revenue by Application (2019-2024)
  9.4.2 Europe Biopharmaceutical Logistic Revenue by Application (2025-2030)
9.5 Europe Biopharmaceutical Logistic Revenue Share by Application (2019-2030)
9.6 Europe Biopharmaceutical Logistic Revenue by Country
  9.6.1 Europe Biopharmaceutical Logistic Revenue by Country (2019 VS 2023 VS 2030)
  9.6.2 Europe Biopharmaceutical Logistic Revenue by Country (2019-2024)
  9.6.3 Europe Biopharmaceutical Logistic Revenue by Country (2025-2030)
  9.6.4 Germany
  9.6.5 France
  9.6.6 U.K.
  9.6.7 Italy
  9.6.8 Russia

10 CHINA

10.1 China Biopharmaceutical Logistic Revenue (2019-2030)
10.2 China Biopharmaceutical Logistic Revenue by Type (2019-2030)
  10.2.1 China Biopharmaceutical Logistic Revenue by Type (2019-2024)
  10.2.2 China Biopharmaceutical Logistic Revenue by Type (2025-2030)
10.3 China Biopharmaceutical Logistic Revenue Share by Type (2019-2030)
10.4 China Biopharmaceutical Logistic Revenue by Application (2019-2030)
  10.4.1 China Biopharmaceutical Logistic Revenue by Application (2019-2024)
  10.4.2 China Biopharmaceutical Logistic Revenue by Application (2025-2030)
10.5 China Biopharmaceutical Logistic Revenue Share by Application (2019-2030)

11 ASIA (EXCLUDING CHINA)

11.1 Asia Biopharmaceutical Logistic Revenue (2019-2030)
11.2 Asia Biopharmaceutical Logistic Revenue by Type (2019-2030)
  11.2.1 Asia Biopharmaceutical Logistic Revenue by Type (2019-2024)
  11.2.2 Asia Biopharmaceutical Logistic Revenue by Type (2025-2030)
11.3 Asia Biopharmaceutical Logistic Revenue Share by Type (2019-2030)
11.4 Asia Biopharmaceutical Logistic Revenue by Application (2019-2030)
  11.4.1 Asia Biopharmaceutical Logistic Revenue by Application (2019-2024)
  11.4.2 Asia Biopharmaceutical Logistic Revenue by Application (2025-2030)
11.5 Asia Biopharmaceutical Logistic Revenue Share by Application (2019-2030)
11.6 Asia Biopharmaceutical Logistic Revenue by Country
  11.6.1 Asia Biopharmaceutical Logistic Revenue by Country (2019 VS 2023 VS 2030)
  11.6.2 Asia Biopharmaceutical Logistic Revenue by Country (2019-2024)
  11.6.3 Asia Biopharmaceutical Logistic Revenue by Country (2025-2030)
  11.6.4 Japan
  11.6.5 South Korea
  11.6.6 India
  11.6.7 Australia
  11.6.8 China Taiwan
  11.6.9 Southeast Asia

12 MIDDLE EAST, AFRICA, LATIN AMERICA

12.1 MEALA Biopharmaceutical Logistic Revenue (2019-2030)
12.2 MEALA Biopharmaceutical Logistic Revenue by Type (2019-2030)
  12.2.1 MEALA Biopharmaceutical Logistic Revenue by Type (2019-2024)
  12.2.2 MEALA Biopharmaceutical Logistic Revenue by Type (2025-2030)
12.3 MEALA Biopharmaceutical Logistic Revenue Share by Type (2019-2030)
12.4 MEALA Biopharmaceutical Logistic Revenue by Application (2019-2030)
  12.4.1 MEALA Biopharmaceutical Logistic Revenue by Application (2019-2024)
  12.4.2 MEALA Biopharmaceutical Logistic Revenue by Application (2025-2030)
12.5 MEALA Biopharmaceutical Logistic Revenue Share by Application (2019-2030)
12.6 MEALA Biopharmaceutical Logistic Revenue by Country
  12.6.1 MEALA Biopharmaceutical Logistic Revenue by Country (2019 VS 2023 VS 2030)
  12.6.2 MEALA Biopharmaceutical Logistic Revenue by Country (2019-2024)
  12.6.3 MEALA Biopharmaceutical Logistic Revenue by Country (2025-2030)
  12.6.4 Mexico
  12.6.5 Brazil
  12.6.6 Israel
  12.6.7 Argentina
  12.6.8 Colombia
  12.6.9 Turkey
  12.6.10 Saudi Arabia
  12.6.11 UAE

13 CONCLUDING INSIGHTS

14 APPENDIX

14.1 Reasons for Doing This Study
14.2 Research Methodology
14.3 Research Process
14.4 Authors List of This Report
14.5 Data Source
  14.5.1 Secondary Sources
  14.5.2 Primary Sources
14.6 Disclaimer
LIST OF TABLES

Table 1. Global Biopharmaceutical Logistic Market Size Growth Rate by Type (US$ Million), 2019 VS 2023 VS 2030
Table 1. Cold Chain Logistics Major Manufacturers
Table 2. Non-cold Chain Logistics Major Manufacturers
Table 3. Global Biopharmaceutical Logistic Market Size Growth Rate by Application (US$ Million), 2019 VS 2023 VS 2030
Table 4. Ground Shipping Major Manufacturers
Table 5. Sea Shipping Major Manufacturers
Table 6. Air Shipping Major Manufacturers
Table 7. Biopharmaceutical Logistic Industry Trends
Table 8. Biopharmaceutical Logistic Industry Drivers
Table 9. Biopharmaceutical Logistic Industry Opportunities and Challenges
Table 10. Biopharmaceutical Logistic Industry Restraints
Table 11. Global Biopharmaceutical Logistic Market Size Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030
Table 12. Global Biopharmaceutical Logistic Market Size by Region (2019-2024) & (US$ Million)
Table 13. Global Biopharmaceutical Logistic Market Share by Region (2019-2024)
Table 14. Global Biopharmaceutical Logistic Market Size by Region (2025-2030) & (US$ Million)
Table 15. Global Biopharmaceutical Logistic Market Share by Region (2025-2030)
Table 16. Global Biopharmaceutical Logistic Revenue by Players (US$ Million) & (2019-2024)
Table 17. Global Biopharmaceutical Logistic Revenue Market Share by Players (2019-2024)
Table 18. Global Biopharmaceutical Logistic Key Players Ranking, 2022 VS 2023 VS 2024
Table 19. Global Biopharmaceutical Logistic Key Players Headquarters & Area Served
Table 20. Global Biopharmaceutical Logistic Players, Product Type & Application
Table 21. Global Biopharmaceutical Logistic Players Commercialization Time
Table 22. Global Players Market Concentration Ratio (CR5 and HHI)
Table 23. Global Biopharmaceutical Logistic by Players Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2023)
Table 24. Global Biopharmaceutical Logistic Revenue by Type 2019 VS 2023 VS 2030 (US$ Million)
Table 25. Global Biopharmaceutical Logistic Revenue by Type (2019-2024) & (US$ Million)
Table 26. Global Biopharmaceutical Logistic Revenue by Type (2025-2030) & (US$ Million)
Table 27. Global Biopharmaceutical Logistic Revenue Market Share by Type (2019-2024) & (US$ Million)
Table 28. Global Biopharmaceutical Logistic Revenue Market Share by Type (2025-2030) & (US$ Million)
Table 29. Global Biopharmaceutical Logistic Revenue by Application 2019 VS 2023 VS 2030 (US$ Million)
Table 30. Global Biopharmaceutical Logistic Revenue by Application (2019-2024) & (US$ Million)
Table 31. Global Biopharmaceutical Logistic Revenue by Application (2025-2030) & (US$ Million)
Table 32. Global Biopharmaceutical Logistic Revenue Market Share by Application (2019-2024) & (US$ Million)
Table 33. Global Biopharmaceutical Logistic Revenue Market Share by Application (2025-2030) & (US$ Million)
Table 34. Deutsche Post DHL Company Information
Table 35. Deutsche Post DHL Business Overview
Table 36. Deutsche Post DHL Biopharmaceutical Logistic Revenue and Gross Margin (US$ Million) & (2019-2024)
Table 37. Deutsche Post DHL Biopharmaceutical Logistic Product Portfolio
Table 38. Deutsche Post DHL Recent Development
Table 39. Kuehne + Nagel Company Information
Table 40. Kuehne + Nagel Business Overview
Table 41. Kuehne + Nagel Biopharmaceutical Logistic Revenue and Gross Margin (US$ Million) & (2019-2024)
Table 42. Kuehne + Nagel Biopharmaceutical Logistic Product Portfolio
Table 43. Kuehne + Nagel Recent Development
Table 44. FedEx Company Information
Table 45. FedEx Business Overview
Table 46. FedEx Biopharmaceutical Logistic Revenue and Gross Margin (US$ Million) & (2019-2024)
Table 47. FedEx Biopharmaceutical Logistic Product Portfolio
Table 48. FedEx Recent Development
Table 49. AmerisourceBergen Company Information
Table 50. AmerisourceBergen Business Overview
Table 51. AmerisourceBergen Biopharmaceutical Logistic Revenue and Gross Margin (US$ Million) & (2019-2024)
Table 52. AmerisourceBergen Biopharmaceutical Logistic Product Portfolio
Table 53. AmerisourceBergen Recent Development
Table 54. UPS (Marken) Company Information
Table 55. UPS (Marken) Business Overview
Table 56. UPS (Marken) Biopharmaceutical Logistic Revenue and Gross Margin (US$ Million) & (2019-2024)
Table 57. UPS (Marken) Biopharmaceutical Logistic Product Portfolio
Table 58. UPS (Marken) Recent Development
Table 59. DB Schenker Company Information
Table 60. DB Schenker Business Overview
Table 61. DB Schenker Biopharmaceutical Logistic Revenue and Gross Margin (US$ Million) & (2019-2024)
Table 62. DB Schenker Biopharmaceutical Logistic Product Portfolio
Table 63. DB Schenker Recent Development
Table 64. XPO Logistics Company Information
Table 65. XPO Logistics Business Overview
Table 66. XPO Logistics Biopharmaceutical Logistic Revenue and Gross Margin (US$ Million) & (2019-2024)
Table 67. XPO Logistics Biopharmaceutical Logistic Product Portfolio
Table 68. XPO Logistics Recent Development
Table 69. Panalpina Company Information
Table 70. Panalpina Business Overview
Table 71. Panalpina Biopharmaceutical Logistic Revenue and Gross Margin (US$ Million) & (2019-2024)
Table 72. Panalpina Biopharmaceutical Logistic Product Portfolio
Table 73. Panalpina Recent Development
Table 74. Nippon Express Company Information
Table 75. Nippon Express Business Overview
Table 76. Nippon Express Biopharmaceutical Logistic Revenue and Gross Margin (US$ Million) & (2019-2024)
Table 77. Nippon Express Biopharmaceutical Logistic Product Portfolio
Table 78. Nippon Express Recent Development
Table 79. GEODIS Company Information
Table 80. GEODIS Business Overview
Table 81. GEODIS Biopharmaceutical Logistic Revenue and Gross Margin (US$ Million) & (2019-2024)
Table 82. GEODIS Biopharmaceutical Logistic Product Portfolio
Table 83. GEODIS Recent Development
Table 84. VersaCold Company Information
Table 85. VersaCold Business Overview
Table 86. VersaCold Biopharmaceutical Logistic Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 87. VersaCold Biopharmaceutical Logistic Product Portfolio
Table 88. VersaCold Recent Development
Table 89. Agility Company Information
Table 90. Agility Business Overview
Table 91. Agility Biopharmaceutical Logistic Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 92. Agility Biopharmaceutical Logistic Product Portfolio
Table 93. Agility Recent Development
Table 94. DSV Company Information
Table 95. DSV Business Overview
Table 96. DSV Biopharmaceutical Logistic Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 97. DSV Biopharmaceutical Logistic Product Portfolio
Table 98. DSV Recent Development
Table 99. Sinotrans Company Information
Table 100. Sinotrans Business Overview
Table 101. Sinotrans Biopharmaceutical Logistic Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 102. Sinotrans Biopharmaceutical Logistic Product Portfolio
Table 103. Sinotrans Recent Development
Table 104. Kerry Logistics Company Information
Table 105. Kerry Logistics Business Overview
Table 106. Kerry Logistics Biopharmaceutical Logistic Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 107. Kerry Logistics Biopharmaceutical Logistic Product Portfolio
Table 108. Kerry Logistics Recent Development
Table 109. SF Express Company Information
Table 110. SF Express Business Overview
Table 111. SF Express Biopharmaceutical Logistic Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 112. SF Express Biopharmaceutical Logistic Product Portfolio
Table 113. SF Express Recent Development
Table 114. CEVA Company Information
Table 115. CEVA Business Overview
Table 116. CEVA Biopharmaceutical Logistic Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 117. CEVA Biopharmaceutical Logistic Product Portfolio
Table 118. CEVA Recent Development
Table 119. CH Robinson Company Information
Table 120. CH Robinson Business Overview
Table 121. CH Robinson Biopharmaceutical Logistic Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 122. CH Robinson Biopharmaceutical Logistic Product Portfolio
Table 123. CH Robinson Recent Development
Table 124. Air Canada Cargo Company Information
Table 125. Air Canada Cargo Business Overview
Table 126. Air Canada Cargo Biopharmaceutical Logistic Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 127. Air Canada Cargo Biopharmaceutical Logistic Product Portfolio
Table 128. Air Canada Cargo Recent Development
Table 129. North America Biopharmaceutical Logistic Revenue by Type (2019-2024) & (US$ Million)
Table 130. North America Biopharmaceutical Logistic Revenue by Application (2019-2024) & (US$ Million)
Table 131. North America Biopharmaceutical Logistic Revenue by Country (2019 VS 2023 VS 2030) & (US$ Million)
Table 132. North America Biopharmaceutical Logistic Revenue by Country (2019-2024) & (US$ Million)
Table 133. North America Biopharmaceutical Logistic Revenue by Country (2025-2030) & (US$ Million)
Table 134. Europe Biopharmaceutical Logistic Revenue by Type (2019-2024) & (US$ Million)
Table 135. Europe Biopharmaceutical Logistic Revenue by Application (2019-2024) & (US$ Million)
Table 136. Europe Biopharmaceutical Logistic Revenue by Country (2019 VS 2023 VS 2030) & (US$ Million)
Table 137. Europe Biopharmaceutical Logistic Revenue by Country (2019-2024) & (US$ Million)
Table 138. Europe Biopharmaceutical Logistic Revenue by Country (2025-2030) & (US$ Million)
Table 139. China Biopharmaceutical Logistic Revenue by Type (2019-2024) & (US$ Million)
Table 140. China Biopharmaceutical Logistic Revenue by Application (2019-2024) & (US$ Million)
Table 141. Asia Biopharmaceutical Logistic Revenue by Type (2019-2024) & (US$ Million)
Table 142. Asia Biopharmaceutical Logistic Revenue by Application (2019-2024) & (US$ Million)
Table 143. Asia Biopharmaceutical Logistic Revenue by Country (2019 VS 2023 VS 2030) & (US$ Million)
Table 144. Asia Biopharmaceutical Logistic Revenue by Country (2019-2024) & (US$ Million)
Table 145. Asia Biopharmaceutical Logistic Revenue by Country (2025-2030) & (US$ Million)
Table 146. MEALA Biopharmaceutical Logistic Revenue by Type (2019-2024) & (US$ Million)
Table 147. MEALA Biopharmaceutical Logistic Revenue by Application (2019-2024) & (US$ Million)
Table 148. MEALA Biopharmaceutical Logistic Revenue by Country (2019 VS 2023 VS 2030) & (US$ Million)
Table 149. MEALA Biopharmaceutical Logistic Revenue by Country (2019-2024) & (US$ Million)
Table 150. MEALA Biopharmaceutical Logistic Revenue by Country (2025-2030) & (US$ Million)
Table 151. Research Programs/Design for This Report
Table 152. Authors List of This Report
Table 153. Secondary Sources
Table 154. Primary Sources

LIST OF FIGURES

Figure 1. Biopharmaceutical Logistic Product Picture
Figure 2. Global Biopharmaceutical Logistic Market Size Growth Rate by Type (US$ Million), 2019 VS 2023 VS 2030
Figure 3. Global Biopharmaceutical Logistic Market Size Share 2019 VS 2023 VS 2030
Figure 4. Cold Chain Logistics Picture
Figure 5. Non-cold Chain Logistics Picture
Figure 6. Global Biopharmaceutical Logistic Market Size Growth Rate by Application (US$ Million), 2019 VS 2023 VS 2030
Figure 7. Global Biopharmaceutical Logistic Market Size Share 2019 VS 2023 VS 2030
Figure 8. Ground Shipping Picture
Figure 9. Sea Shipping Picture
Figure 10. Air Shipping Picture
Figure 11. Global Biopharmaceutical Logistic Market Size (US$ Million) & (2019-2030)
Figure 12. Global Biopharmaceutical Logistic Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 13. Global Biopharmaceutical Logistic Market Share by Region: 2019 VS 2023 VS 2030
Figure 14. Global Biopharmaceutical Logistic Players Revenue Share Top 10 and Top 5 in 2023
Figure 15. Players Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 16. Global Biopharmaceutical Logistic Revenue by Type (2019 VS 2023 VS 2030) & (US$ Million)
Figure 17. Global Biopharmaceutical Logistic Revenue Market Share 2019 VS 2023 VS 2030
Figure 18. Global Biopharmaceutical Logistic Revenue Market Share by Type (2019-2030)
Figure 19. Global Biopharmaceutical Logistic Revenue by Application (2019 VS 2023 VS 2030) & (US$ Million)
Figure 20. Global Biopharmaceutical Logistic Revenue Market Share by Application (2019 VS 2023 VS 2030)
Figure 21. Global Biopharmaceutical Logistic Revenue Market Share by Application (2019-2030)
Figure 22. North America Biopharmaceutical Logistic Revenue YoY Growth (2019-2030) & (US$ Million)
Figure 23. North America Biopharmaceutical Logistic Revenue by Type (2025-2030) & (US$ Million)
Figure 24. North America Biopharmaceutical Logistic Revenue Share by Type (2019-2030)
Figure 25. North America Biopharmaceutical Logistic Revenue by Application (2025-2030) & (US$ Million)
Figure 26. North America Biopharmaceutical Logistic Revenue Share by Application (2019-2030)
Figure 27. North America Biopharmaceutical Logistic Revenue Share by Country (2019-2030)
Figure 28. United States Biopharmaceutical Logistic Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 29. Canada Biopharmaceutical Logistic Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 30. Europe Biopharmaceutical Logistic Revenue YoY Growth (2019-2030) & (US$ Million)
Figure 31. Europe Biopharmaceutical Logistic Revenue by Type (2025-2030) & (US$ Million)
Figure 32. Europe Biopharmaceutical Logistic Revenue Share by Type (2019-2030)
Figure 33. Europe Biopharmaceutical Logistic Revenue by Application (2025-2030) & (US$ Million)
Figure 34. Europe Biopharmaceutical Logistic Revenue Share by Application (2019-2030)
Figure 35. Europe Biopharmaceutical Logistic Revenue Share by Country (2019-2030)
Figure 36. Germany Biopharmaceutical Logistic Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 37. France Biopharmaceutical Logistic Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 38. U.K. Biopharmaceutical Logistic Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 39. Italy Biopharmaceutical Logistic Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 40. Russia Biopharmaceutical Logistic Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 41. Nordic Countries Biopharmaceutical Logistic Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 42. China Biopharmaceutical Logistic Revenue YoY Growth (2019-2030) & (US$ Million)
Figure 43. China Biopharmaceutical Logistic Revenue by Type (2025-2030) & (US$ Million)
Figure 44. China Biopharmaceutical Logistic Revenue Share by Type (2019-2030)
Figure 45. China Biopharmaceutical Logistic Revenue by Application (2025-2030) & (US$ Million)
Figure 46. China Biopharmaceutical Logistic Revenue Share by Application (2019-2030)
Figure 47. Asia Biopharmaceutical Logistic Revenue YoY Growth (2019-2030) & (US$ Million)
Figure 48. Asia Biopharmaceutical Logistic Revenue by Type (2025-2030) & (US$ Million)
Figure 49. Asia Biopharmaceutical Logistic Revenue Share by Type (2019-2030)
Figure 50. Asia Biopharmaceutical Logistic Revenue by Application (2025-2030) & (US$ Million)
Figure 51. Asia Biopharmaceutical Logistic Revenue Share by Application (2019-2030)
Figure 52. Asia Biopharmaceutical Logistic Revenue Share by Country (2019-2030)
Figure 53. Japan Biopharmaceutical Logistic Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 54. South Korea Biopharmaceutical Logistic Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 55. India Biopharmaceutical Logistic Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 56. Australia Biopharmaceutical Logistic Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 57. China Taiwan Biopharmaceutical Logistic Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 58. Southeast Asia Biopharmaceutical Logistic Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 59. MEALA Biopharmaceutical Logistic Revenue YoY Growth (2019-2030) & (US$ Million)
Figure 60. MEALA Biopharmaceutical Logistic Revenue by Type (2025-2030) & (US$ Million)
Figure 61. MEALA Biopharmaceutical Logistic Revenue Share by Type (2019-2030)
Figure 62. MEALA Biopharmaceutical Logistic Revenue by Application (2025-2030) & (US$ Million)
Figure 63. MEALA Biopharmaceutical Logistic Revenue Share by Application (2019-2030)
Figure 64. MEALA Biopharmaceutical Logistic Revenue Share by Country (2019-2030)
Figure 65. Mexico Biopharmaceutical Logistic Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 66. South Korea Biopharmaceutical Logistic Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 67. Brazil Biopharmaceutical Logistic Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 68. Israel Biopharmaceutical Logistic Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 69. Argentina Biopharmaceutical Logistic Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 70. Colombia Biopharmaceutical Logistic Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 71. Turkey Biopharmaceutical Logis


More Publications